Animal Model For Schizophrenia Identifies Novel Approach For Treating Cognitive Impairments Associated With Schizophrenia

Researchers have been seeking a safe and effective way to treat cognitive impairments associated with schizophrenia by enhancing N-methyl-D-aspartate (NMDA) glutamate receptors. Functional deficits in NMDA receptors may contribute to the underlying neurobiology of this disorder.

Read the whole article on Science Daily

More from Science Daily